Genetic polymorphisms and lung cancer susceptibility: a review (Q34863207)

5 August 2017

1 reference

title

Genetic polymorphisms and lung cancer susceptibility: a review (English)

1 reference

5 August 2017

1 reference

Chikako Kiyohara

1

1 reference

5 August 2017

Akiko Otsu

2

1 reference

5 August 2017

Taro Shirakawa

3

1 reference

5 August 2017

Sanae Fukuda

4

1 reference

5 August 2017

Julian M Hopkin

5

1 reference

5 August 2017

1 September 2002

1 reference

5 August 2017

1 reference

5 August 2017

37

1 reference

5 August 2017

3

1 reference

5 August 2017

241-256

1 reference

Passive smoking and lung cancer risk: what is the story now?

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

The accumulated evidence on lung cancer and environmental tobacco smoke

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

The human microsomal epoxide hydrolase gene (EPHX1): complete nucleotide sequence and structural characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Mammalian Epoxide Hydrases: Inducible Enzymes Catalysing the Inactivation of Carcinogenic and Cytotoxic Metabolites Derived from Aromatic and Olefinic Compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Benzo[alpha]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Targeted disruption of the microsomal epoxide hydrolase gene. Microsomal epoxide hydrolase is required for the carcinogenic activity of 7,12-dimethylbenz[a]anthracene

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Lung cancer susceptibility in relation to combined polymorphisms of microsomal epoxide hydrolase and glutathione S-transferase P1.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Lung cancer risk in relation to genetic polymorphisms of microsomal epoxide hydrolase among African-Americans and Caucasians in Los Angeles County.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

The association of microsomal epoxide hydrolase polymorphisms and lung cancer risk in African-Americans and Mexican-Americans

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Association of CYP1A1 and microsomal epoxide hydrolase polymorphisms with lung squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

NAD(P)H:quinone oxidoreductase1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Cytosolic activation of aromatic and heterocyclic amines. Inhibition by dicoumarol and enhancement in viral hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Polymorphisms in the NAD(P)H: quinone oxidoreductase gene and small cell lung cancer risk in a UK population

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

NAD(P)H: quinone oxidoreductase polymorphism and lung cancer in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Myeloperoxidase in human lung lavage. II. Internalization of myeloperoxidase by alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Myeloperoxidase in human lung lavage. I. A marker of local neutrophil activity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Assessment of chlorination by human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Interactions of hypochlorous acid with pyrimidine nucleotides, and secondary reactions of chlorinated pyrimidines with GSH, NADH, and other substrates

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Peroxidase-catalyzed benzidine binding to DNA and other macromolecules

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Oxidant-dependent metabolic activation of polycyclic aromatic hydrocarbons by phorbol ester-stimulated human polymorphonuclear leukocytes: possible link between inflammation and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Activation of (+-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to diolepoxides by human polymorphonuclear leukocytes or myeloperoxidase.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Myeloperoxidase-enhanced formation of (+-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene-DNA adducts in lung tissue in vitro: a role of pulmonary inflammation in the bioactivation of a procarcinogen

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Determination of the enzymes responsible for activation of the heterocyclic amine 2-amino-3-methylimidazo[4,5-f]quinoline in the human breast

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Variation in the promoter region of the myeloperoxidase gene is not directly related to lung cancer risk among male smokers in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Defective Repair Replication of DNA in Xeroderma Pigmentosum

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

DNA repair in eukaryotes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Cigarette smoking induces an increase in oxidative DNA damage, 8-hydroxydeoxyguanosine, in a central site of the human lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Impaired DNA repair capacity in skin fibroblasts from various hereditary cancer-prone syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Mice with DNA repair gene (ERCC-1) deficiency have elevated levels of p53, liver nuclear abnormalities and die before weaning

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

ERCC6, a member of a subfamily of putative helicases, is involved in Cockayne's syndrome and preferential repair of active genes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Genetic polymorphism of XRCC1 and lung cancer risk among African-Americans and Caucasians.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Genetic polymorphisms in DNA repair genes and risk of lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Mutagenicity and repair of oxidative DNA damage: insights from studies using defined lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Loss of heterozygosity of the human cytosolic glutathione peroxidase I gene in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Primary structure of human plasma glutathione peroxidase deduced from cDNA sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Phenotype determination of a common Pro-Leu polymorphism in human glutathione peroxidase 1

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

The effect of hOGG1 and glutathione peroxidase I genotypes and 3p chromosomal loss on 8-hydroxydeoxyguanosine levels in lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

A mammalian DNA repair enzyme that excises oxidatively damaged guanines maps to a locus frequently lost in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

hOGG1 polymorphism and loss of heterozygosity (LOH): significance for lung cancer susceptibility in a caucasian population

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Codon 72 polymorphism of the TP53 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Gene defect identified in common hereditary colon cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Tumor suppressor genes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

The importance of p53 gene alterations in human cancer: is there more than circumstantial evidence?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

p53 function and dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

p53: the promising story continues to unfold

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

p53: at the crossroads of molecular carcinogenesis and risk assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Introduction: p53--the first twenty years

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

P53 polymorphisms and haplotypes in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Germ line polymorphisms of the tumor suppressor gene p53 and lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

The glutathione S-transferases: polymerase chain reaction studies on the frequency of the GSTM1 0 genotype in patients with pituitary adenomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

Environment institute lays plans for gene hunt

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900107-1

7 January 2021

10.1016/S0169-5002(02)00107-1

Identifiers

DOI

1 reference

5 August 2017

1 reference